Anti-Müllerian Hormone and Its Predictive Utility in Assisted Reproductive Technologies Outcomes.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Anti-Müllerian Hormone and Its Predictive Utility in Assisted Reproductive Technologies Outcomes.
- Published In:
- Clinical obstetrics and gynecology, 62(2), 238-256 (2019)
- Authors:
- Granger, Emily, Tal, Reshef
- Database ID:
- RPEP-04203
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-04203APA
Granger, Emily; Tal, Reshef. (2019). Anti-Müllerian Hormone and Its Predictive Utility in Assisted Reproductive Technologies Outcomes.. Clinical obstetrics and gynecology, 62(2), 238-256. https://doi.org/10.1097/GRF.0000000000000436
MLA
Granger, Emily, et al. "Anti-Müllerian Hormone and Its Predictive Utility in Assisted Reproductive Technologies Outcomes.." Clinical obstetrics and gynecology, 2019. https://doi.org/10.1097/GRF.0000000000000436
RethinkPeptides
RethinkPeptides Research Database. "Anti-Müllerian Hormone and Its Predictive Utility in Assiste..." RPEP-04203. Retrieved from https://rethinkpeptides.com/research/granger-2019-antimllerian-hormone-and-its
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.